Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Plos One|November 20, 2009
Longitudinal evaluation of an N-ethyl-N-nitrosourea-created murine model with normal pressure hydrocephalusMing-Jen Lee, Ching-Pang Chang, Yi-Hsin Lee, et al.
Frontiers in Molecular Neuroscience|July 28, 2018
Beneficial Effect of a Selective Adenosine A2A Receptor Antagonist in the APPswe/PS1dE9 Mouse Model of Alzheimer's DiseaseEmilie Faivre, Joana E Coelho, Katja Zornbach, et al.
Acta Neuropathologica Communications|June 23, 2021
Equilibrative nucleoside transporter 1 inhibition rescues energy dysfunction and pathology in a model of tauopathyChing-Pang Chang, Ya-Gin Chang, Pei-Yun Chuang, et al.
The International Journal of Biochemistry & Cell Biology|September 18, 2024
PIAS1 S510G variant acts as a genetic modifier of spinocerebellar ataxia type 3 by selectively impairing mutant ataxin-3 proteostasisYi-Ching Chang, Yao-Chou Tsai, En-Cheng Chang, et al.
Plos One|June 30, 2011
A new drug design targeting the adenosinergic system for Huntington's diseaseNai-Kuei Huang, Jung-Hsin Lin, Jiun-Tsai Lin, et al.
Brain : a Journal of Neurology|October 11, 2019
Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptorKevin Carvalho, Emilie Faivre, Marie J Pietrowski, et al.
The Journal of Clinical Investigation|November 21, 2023
Galectin-3 aggravates microglial activation and tau transmission in tauopathyJian Jing Siew, Hui-Mei Chen, Feng-Lan Chiu, et al.
Pageof 13